Redox Stock
Data integrator between hospitals and digital health apps
Sign up today and learn more about Redox Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Redox Stock
Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better.
Funding History
| November 2014 | $470K |
|---|---|
| October 2015 | $3.5M |
| January 2017 | $9.0M |
| April 2017 | $1.0M |
| August 2018 | $3.0M |
| April 2019 | $33.0M |
Management
Software Developer
Andy Kitson
Co-founder
Niko Skievaski
Director
Liam Donohue
Co-founder
James Lloyd
Marketing and Developer Advocate
George Mclaughlin
Software Developer
Christopher "TC" Tobin-Campbell
Product
Nijay Patel
Director of Implementation
Devin Soelberg
HL7 Whisperer
Nick Hatt
Co-founder
Luke Bonney
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
